
Orano SA Business Model Canvas
Unlock the full strategic blueprint behind Orano SA’s business model: this concise Business Model Canvas maps value propositions, key partners, revenue streams, and cost drivers to reveal how Orano secures market position in nuclear fuel and recycling—download the complete Word/Excel canvas for a ready-to-use, investor-grade strategic tool.
Partnerships
The French state, holding a ~40% stake in Orano SA as of 2025, remains a primary shareholder and strategic partner, aligning the company with national energy sovereignty and security priorities. Collaboration with the French Alternative Energies and Atomic Energy Commission (CEA) secures joint R&D funding—Orano reported €120m in public-supported R&D in 2024—and provides a stable regulatory framework for multi-decade fuel-cycle operations.
Orano partners with national and private entities to operate uranium mines worldwide, notably Katco with Kazatomprom in Kazakhstan (Orano stake ~49.9%) and ventures in Canada (McClean Lake ore processing; Orano stake 36.6%), securing ~7%–9% of global mined uranium in 2024 and reducing supply risk by sharing capital and operational costs.
Orano SA depends on specialized industrial suppliers for construction and upkeep of facilities like the Philippe Coste conversion plant; in 2024 Orano spent ~€220M on CAPEX related to conversion and recycling assets, a portion tied to supplier contracts for centrifuges, specialty chemicals and heavy machinery.
Maintaining long-term vendor agreements—some covering service, spare parts and R&D co‑funding—keeps uptime above 92% at key sites and ensures rapid integration of new enrichment and recycling technologies.
Logistics and Transport Networks
Orano contracts specialized maritime, rail and road carriers to move uranium ore, UF6 and recycled fuel under strict IAEA and ADR/IMDG rules, handling ~150 shipments/year and supporting ~€3.7bn in 2024 group revenue-linked operations.
These partners enforce ISPS-level security, GPS-tracked convoys, and certified radiological packaging to meet cross-border customs and safety protocols, keeping on-time delivery rates above 95% in 2024.
- ~150 regulated shipments/year
- €3.7bn revenue exposure (2024)
- 95%+ on-time delivery (2024)
- IAEA, ADR, IMDG compliance
- GPS tracking + certified packaging
Academic and Scientific Research Bodies
- 50 GBq/month Lead-212 pilot capacity (2024)
- ~30% unit cost reduction vs 2021
- 120 joint PhDs since 2020
- ~45 hires from partnerships (2023–2025)
Orano’s key partners include the French state (~40% stake, 2025), CEA (€120m public R&D support in 2024), JV miners (Katco ~49.9% stake; McClean Lake 36.6%), and logistics/suppliers supporting ~150 regulated shipments/year and €3.7bn revenue exposure (2024), plus universities driving 50 GBq/month Lead‑212 pilots (2024) and 120 joint PhDs since 2020.
| Partner | 2024–25 Key Data |
|---|---|
| French state | ~40% stake (2025) |
| CEA | €120m public R&D (2024) |
| Mining JVs | Katco 49.9%, McClean Lake 36.6%; 7–9% global uranium supply (2024) |
| Logistics/suppliers | ~150 shipments/yr; €3.7bn revenue exposure; 95%+ on-time (2024) |
| Academia | 50 GBq/month Lead‑212; 120 joint PhDs since 2020 |
What is included in the product
A concise Business Model Canvas for Orano SA outlining customer segments, value propositions, channels, key activities, partners, resources, cost structure and revenue streams, reflecting its nuclear fuel cycle services, global operations, regulatory posture and competitive advantages for investor-facing presentations and strategic analysis.
High-level view of Orano SA’s nuclear fuel-cycle business model with editable cells—quickly pinpoint core activities, revenue streams, and regulatory risks for boardrooms or teams.
Activities
Orano explores, extracts and processes uranium into yellowcake across sites in Kazakhstan, Canada and Niger, using geological modelling and In-Situ Recovery (ISR) to cut costs and water use; in 2024 Orano reported 4,600 tU produced (tonnes of uranium) and €2.9B revenue, securing feedstock for its conversion and enrichment units and reducing spot-market exposure.
Orano converts uranium concentrate to uranium hexafluoride (UF6) and enriches it using advanced centrifuge fleets, supplying >20% of Western enrichment needs in 2024 and processing ~4,200 tU (tonnes of uranium) equivalent in 2023; these steps are core to its value chain and revenue mix.
Orano targets a ~15% reduction in energy per SWU (separative work unit) by 2026 through plant upgrades and digital optimization, meeting rising global demand while lowering operating costs.
Orano treats used fuel at La Hague to recover uranium and plutonium—La Hague processed ~6,500 tHM in 2024—and ships recovered plutonium to Melox for MOX (mixed oxide) fabrication; Melox produced ~1,100 t of MOX fuel in 2024, supplying ~10% of French reactor needs.
Nuclear Medicine and Isotope Production
Orano Med develops lead-212 (Pb-212) for Targeted Alpha Therapy, extracting isotopes from spent nuclear material and advancing radiopharmaceuticals through clinical trials; Pb-212 programs target oncology markets with projected CAGRs >15% to 2030 and address ~2.5M annual new cancer cases in Western markets.
- Leverages Orano’s nuclear processing: existing facilities, €100M+ capex since 2022
- Pb-212: short half-life, high potency for micrometastases
- Clinical pipeline: multiple Phase I/II studies (2024–2026)
Decommissioning and Waste Management
Orano provides turnkey decommissioning and radioactive waste-management services, covering dismantling, radiological characterization, and design of secure storage for low- to high-level waste; in 2024 Orano reported ~€1.2bn revenues from recycling and services, with decommissioning contracts growing ~8% YoY as global plant retirements rise.
- Specialized dismantling and engineering
- Radiological characterization and waste sorting
- Secure storage solutions for all waste classes
- Marketed globally to operators amid rising retirements
- ~€1.2bn services revenue (2024), decommissioning +8% YoY
Orano mines/processes uranium (4,600 tU, €2.9B rev 2024), converts/enriches (~4,200 tU processed 2023; >20% Western SWU supply), treats used fuel (La Hague 6,500 tHM 2024) and makes MOX (1,100 t 2024), runs decommissioning/waste services (~€1.2B 2024) and develops Pb-212 radiopharma (clinical pipeline).
| Activity | 2024/2023 |
|---|---|
| Mining | 4,600 tU; €2.9B |
| Fuel cycle | 4,200 tU; >20% SWU |
| Reprocessing | 6,500 tHM |
| MOX | 1,100 t |
| Services | €1.2B |
Delivered as Displayed
Business Model Canvas
The document you're previewing on this page is the real Orano SA Business Model Canvas—not a mockup or sample—but a direct snapshot of the actual file you’ll receive after purchase.
When you complete your order, you’ll get full access to this exact, professionally formatted Business Model Canvas, structured the same way as shown here with all content included.
No surprises or fillers: the purchased file is ready to edit, present, and share in the same layout and detail you see in the preview.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Unlock the full strategic blueprint behind Orano SA’s business model: this concise Business Model Canvas maps value propositions, key partners, revenue streams, and cost drivers to reveal how Orano secures market position in nuclear fuel and recycling—download the complete Word/Excel canvas for a ready-to-use, investor-grade strategic tool.
Partnerships
The French state, holding a ~40% stake in Orano SA as of 2025, remains a primary shareholder and strategic partner, aligning the company with national energy sovereignty and security priorities. Collaboration with the French Alternative Energies and Atomic Energy Commission (CEA) secures joint R&D funding—Orano reported €120m in public-supported R&D in 2024—and provides a stable regulatory framework for multi-decade fuel-cycle operations.
Orano partners with national and private entities to operate uranium mines worldwide, notably Katco with Kazatomprom in Kazakhstan (Orano stake ~49.9%) and ventures in Canada (McClean Lake ore processing; Orano stake 36.6%), securing ~7%–9% of global mined uranium in 2024 and reducing supply risk by sharing capital and operational costs.
Orano SA depends on specialized industrial suppliers for construction and upkeep of facilities like the Philippe Coste conversion plant; in 2024 Orano spent ~€220M on CAPEX related to conversion and recycling assets, a portion tied to supplier contracts for centrifuges, specialty chemicals and heavy machinery.
Maintaining long-term vendor agreements—some covering service, spare parts and R&D co‑funding—keeps uptime above 92% at key sites and ensures rapid integration of new enrichment and recycling technologies.
Logistics and Transport Networks
Orano contracts specialized maritime, rail and road carriers to move uranium ore, UF6 and recycled fuel under strict IAEA and ADR/IMDG rules, handling ~150 shipments/year and supporting ~€3.7bn in 2024 group revenue-linked operations.
These partners enforce ISPS-level security, GPS-tracked convoys, and certified radiological packaging to meet cross-border customs and safety protocols, keeping on-time delivery rates above 95% in 2024.
- ~150 regulated shipments/year
- €3.7bn revenue exposure (2024)
- 95%+ on-time delivery (2024)
- IAEA, ADR, IMDG compliance
- GPS tracking + certified packaging
Academic and Scientific Research Bodies
- 50 GBq/month Lead-212 pilot capacity (2024)
- ~30% unit cost reduction vs 2021
- 120 joint PhDs since 2020
- ~45 hires from partnerships (2023–2025)
Orano’s key partners include the French state (~40% stake, 2025), CEA (€120m public R&D support in 2024), JV miners (Katco ~49.9% stake; McClean Lake 36.6%), and logistics/suppliers supporting ~150 regulated shipments/year and €3.7bn revenue exposure (2024), plus universities driving 50 GBq/month Lead‑212 pilots (2024) and 120 joint PhDs since 2020.
| Partner | 2024–25 Key Data |
|---|---|
| French state | ~40% stake (2025) |
| CEA | €120m public R&D (2024) |
| Mining JVs | Katco 49.9%, McClean Lake 36.6%; 7–9% global uranium supply (2024) |
| Logistics/suppliers | ~150 shipments/yr; €3.7bn revenue exposure; 95%+ on-time (2024) |
| Academia | 50 GBq/month Lead‑212; 120 joint PhDs since 2020 |
What is included in the product
A concise Business Model Canvas for Orano SA outlining customer segments, value propositions, channels, key activities, partners, resources, cost structure and revenue streams, reflecting its nuclear fuel cycle services, global operations, regulatory posture and competitive advantages for investor-facing presentations and strategic analysis.
High-level view of Orano SA’s nuclear fuel-cycle business model with editable cells—quickly pinpoint core activities, revenue streams, and regulatory risks for boardrooms or teams.
Activities
Orano explores, extracts and processes uranium into yellowcake across sites in Kazakhstan, Canada and Niger, using geological modelling and In-Situ Recovery (ISR) to cut costs and water use; in 2024 Orano reported 4,600 tU produced (tonnes of uranium) and €2.9B revenue, securing feedstock for its conversion and enrichment units and reducing spot-market exposure.
Orano converts uranium concentrate to uranium hexafluoride (UF6) and enriches it using advanced centrifuge fleets, supplying >20% of Western enrichment needs in 2024 and processing ~4,200 tU (tonnes of uranium) equivalent in 2023; these steps are core to its value chain and revenue mix.
Orano targets a ~15% reduction in energy per SWU (separative work unit) by 2026 through plant upgrades and digital optimization, meeting rising global demand while lowering operating costs.
Orano treats used fuel at La Hague to recover uranium and plutonium—La Hague processed ~6,500 tHM in 2024—and ships recovered plutonium to Melox for MOX (mixed oxide) fabrication; Melox produced ~1,100 t of MOX fuel in 2024, supplying ~10% of French reactor needs.
Nuclear Medicine and Isotope Production
Orano Med develops lead-212 (Pb-212) for Targeted Alpha Therapy, extracting isotopes from spent nuclear material and advancing radiopharmaceuticals through clinical trials; Pb-212 programs target oncology markets with projected CAGRs >15% to 2030 and address ~2.5M annual new cancer cases in Western markets.
- Leverages Orano’s nuclear processing: existing facilities, €100M+ capex since 2022
- Pb-212: short half-life, high potency for micrometastases
- Clinical pipeline: multiple Phase I/II studies (2024–2026)
Decommissioning and Waste Management
Orano provides turnkey decommissioning and radioactive waste-management services, covering dismantling, radiological characterization, and design of secure storage for low- to high-level waste; in 2024 Orano reported ~€1.2bn revenues from recycling and services, with decommissioning contracts growing ~8% YoY as global plant retirements rise.
- Specialized dismantling and engineering
- Radiological characterization and waste sorting
- Secure storage solutions for all waste classes
- Marketed globally to operators amid rising retirements
- ~€1.2bn services revenue (2024), decommissioning +8% YoY
Orano mines/processes uranium (4,600 tU, €2.9B rev 2024), converts/enriches (~4,200 tU processed 2023; >20% Western SWU supply), treats used fuel (La Hague 6,500 tHM 2024) and makes MOX (1,100 t 2024), runs decommissioning/waste services (~€1.2B 2024) and develops Pb-212 radiopharma (clinical pipeline).
| Activity | 2024/2023 |
|---|---|
| Mining | 4,600 tU; €2.9B |
| Fuel cycle | 4,200 tU; >20% SWU |
| Reprocessing | 6,500 tHM |
| MOX | 1,100 t |
| Services | €1.2B |
Delivered as Displayed
Business Model Canvas
The document you're previewing on this page is the real Orano SA Business Model Canvas—not a mockup or sample—but a direct snapshot of the actual file you’ll receive after purchase.
When you complete your order, you’ll get full access to this exact, professionally formatted Business Model Canvas, structured the same way as shown here with all content included.
No surprises or fillers: the purchased file is ready to edit, present, and share in the same layout and detail you see in the preview.











